Sun H et al (2022) IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 183:109119. https://doi.org/10.1016/j.diabres.2021.109119

Article  PubMed  Google Scholar 

Yun J-S, Ko S-H (2021) Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes. Metabolism 123:154838. https://doi.org/10.1016/j.metabol.2021.154838

Article  CAS  PubMed  Google Scholar 

Bos M, Agyemang C (2013) Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC Public Health 13:387. https://doi.org/10.1186/1471-2458-13-387

Article  PubMed  PubMed Central  Google Scholar 

Albers AR, Krichavsky MZ, Balady GJ (2006) Stress testing in patients with diabetes mellitus: diagnostic and prognostic value. Circulation 113(4):583–592. https://doi.org/10.1161/CIRCULATIONAHA.105.584524

Article  PubMed  Google Scholar 

Acs A, Ludwig C, Bereza BG et al (2017) Prevalence of cardiovascular disease in Type 2 diabetes: a global systematic review. Value Health 20(9):A475

Article  Google Scholar 

Dinesh Shah A et al (2015) Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1·9 million people. Lancet 385(Suppl 1):S86. https://doi.org/10.1016/S0140-6736(15)60401-9

Article  PubMed  Google Scholar 

Sarwar N et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375(9733):2215–2222. https://doi.org/10.1016/S0140-6736(10)60484-9

Article  CAS  PubMed  Google Scholar 

Beckman JA, Paneni F, Cosentino F, Creager MA (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 34(31):2444–2452. https://doi.org/10.1093/eurheartj/eht142

Article  PubMed  Google Scholar 

Norhammar A et al (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359(9324):2140–2144. https://doi.org/10.1016/S0140-6736(02)09089-X

Article  CAS  PubMed  Google Scholar 

De Luca G et al (2009) Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. Atherosclerosis 207(1):181–185. https://doi.org/10.1016/j.atherosclerosis.2009.03.042

Article  CAS  PubMed  Google Scholar 

Ishihara M et al (2007) Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era. Am J Cardiol 99(12):1674–1679. https://doi.org/10.1016/j.amjcard.2007.01.044

Article  PubMed  Google Scholar 

Porter A et al (2008) Impaired fasting glucose and outcomes of ST-elevation acute coronary syndrome treated with primary percutaneous intervention among patients without previously known diabetes mellitus. Am Heart J 155(2):284–289. https://doi.org/10.1016/j.ahj.2007.10.010

Article  PubMed  Google Scholar 

Schmitt VH, Hobohm L, Münzel T et al (2021) Impact of diabetes mellitus on mortality rates and outcomes in myocardial infarction. Diabetes Metab 47(4):101211. https://doi.org/10.1016/j.diabet.2020.11.003

Article  PubMed  Google Scholar 

Capes SE, Hunt D, Malmberg K, Gerstein HC (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355(9206):773–778. https://doi.org/10.1016/S0140-6736(99)08415-9

Article  CAS  PubMed  Google Scholar 

Behar S, Boyko V, Reicher-Reiss H, Goldbourt U (1997) Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J 133(3):290–296. https://doi.org/10.1016/s0002-8703(97)70222-9

Article  CAS  PubMed  Google Scholar 

Afanasiev SA, Garganeeva AA, Kuzheleva EA et al (2018, 2018) The Impact of Type 2 Diabetes Mellitus on Long-Term Prognosis in Patients of Different Ages with Myocardial Infarction. J Diabetes Res:1780683. https://doi.org/10.1155/2018/1780683

Gholap NN, Achana FA, Davies MJ et al (2017) Long-term mortality after acute myocardial infarction among individuals with and without diabetes: A systematic review and meta-analysis of studies in the post-reperfusion era. Diabetes Obes Metab 19(3):364–374. https://doi.org/10.1111/dom.12827

Article  PubMed  Google Scholar 

Chandrasekhar J et al (2020) Impact of insulin treated and non-insulin-treated diabetes compared to patients without diabetes on 1-year outcomes following contemporary PCI. Catheter Cardiovasc Interv 96(2):298–308. https://doi.org/10.1002/ccd.28841

Article  PubMed  Google Scholar 

Iwakura K et al (2003) Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol (1):41, 1–47. https://doi.org/10.1016/s0735-1097(02)02626-8

Ni L, Yuan C, Chen G et al (2020) SGLT2i: beyond the glucose-lowering effect. Cardiovasc Diabetol 19(1):98. https://doi.org/10.1186/s12933-020-01071-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Packer M et al (2020) Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med 383(15):1413–1424. https://doi.org/10.1056/NEJMoa2022190

Article  CAS  PubMed  Google Scholar 

Zinman B et al (2015) Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med 373(22):2117–2128. https://doi.org/10.1056/NEJMoa1504720

Article  CAS  PubMed  Google Scholar 

Anker SD et al (2019) Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial. Eur J Heart Fail 21(10):1279–1287. https://doi.org/10.1002/ejhf.1596

Article  CAS  PubMed  Google Scholar 

Santos-Gallego CG et al (2021) Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol 77(3):243–255. https://doi.org/10.1016/j.jacc.2020.11.008

Article  CAS  PubMed  Google Scholar 

Böhm M et al (2022) ‘Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age. J Am Coll Cardiol 80(1):1–18. https://doi.org/10.1016/j.jacc.2022.04.040

Article  CAS  PubMed  Google Scholar 

Andreadou I, Bell RM, Bøtker HE, Zuurbier CJ (2020) SGLT2 inhibitors reduce infarct size in reperfused ischemic heart and improve cardiac function during ischemic episodes in preclinical models. Biochim Biophys Acta Mol Basis Dis 1866(7):165770. https://doi.org/10.1016/j.bbadis.2020.165770

Article  CAS  PubMed  Google Scholar 

Carvalho LSF et al (2019) Change of BNP between admission and discharge after ST-elevation myocardial infarction (Killip I) improves risk prediction of heart failure, death, and recurrent myocardial infarction compared to single isolated measurement in addition to the GRACE score. Eur Heart J Acute Cardiovasc Care 8(7):643–651. https://doi.org/10.1177/2048872617753049

Article  PubMed  Google Scholar 

Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Rev Esp Cardiol (Engl Ed) 74(9):790–799. https://doi.org/10.1016/j.rec.2021.07.010

Article  PubMed  Google Scholar 

JPT H, Thomas J, Chandler J et al (eds) (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane

Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan—a web and mobile app for systematic reviews. Syst Rev 5(1):210. https://doi.org/10.1186/s13643-016-0384-4

Article  PubMed  PubMed Central  Google Scholar 

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629

Article  CAS